Introducing Exora™, A New Standard in Regenerative Aesthetic Science
Nyenta.com/10344425

NEW YORK - Nyenta -- Exora™, a luxury skin and haircare company built on more than a decade of stem cell research, officially announces its launch. Known for its breakthrough product line, JuveXO® exosomes, the announcement marks a major advancement in the rapidly evolving field of science-based aesthetics beauty products.

Exosome science is transforming how we approach skin health, hair restoration, and regenerative aesthetics. With its foundation deeply rooted in stem cell biology, Exora™ was created to translate advanced biotechnology into a new standard of beauty, one that is intelligent, refined, and grounded in scientific proof.

"At Exora™, our mission is to produce best in class science backed cosmetic products that deliver clinical meaningful results," said Rafael González, PhD, Scientific Advisor at Exora™. "Exosome-based therapies represent a fundamental shift in how we think about using science to become a major player in tissue repair and aesthetic outcomes. Our products, powered by ExoCM™preserve the biological integrity of these signals and applies them in a highly targeted, effective way."

More on Nyenta.com

• SULAAH Expands Lost Files With "THE BEAT" Lyric Video and AI-Assisted Sound Series
• STO Foundation Launching June 29, 2026 to Advance the Global Tokenization Industry
• Nyasia Chane'l Celebrates 5 Years of Clubhouse No. 7 With Deluxe Edition
• West Virginia Leaders Announce Support for Election Integrity Network's Model Election Laws Handbook
• Venture Philanthropy Blueprint by Alain Leroy Published

At the core of Exora™'s innovation is ExoCM™, a proprietary bioactive secretome matrix derived from Umbilical Cord Lining Stem Cells (ULSCs), recognized as a superior source of Mesenchymal Stem Cells (MSCs). This advanced complex is rich in naturally occurring components intrinsic to cellular biology, featuring Exosomes, Collagen Types I & III, High Molecular Weight Hyaluronic Acid, Beta-defensins, Glutathione, and Peptides.

These ULSC-derived exosomes are naturally secreted, abundant in native bioactive molecules, and biologically aligned with the skin and scalp's molecular architecture, enabling what Exora™ describes as a "biological dialogue" rather than a surface-level treatment.

The company's hero product, JuveXO®, is a premium secretome-powered formulation designed to support visible skin and hair rejuvenation by working with the body's natural regenerative processes. Already recognized within the professional aesthetics community, JuveXO® represents a new category of clinically informed topical solutions designed to elevate daily care.

More on Nyenta.com

• CCHR Condemns Behavioral Treatment After FDA's Missed Deadline to Ban Shock Device
• VINCE Magazine Launches New Digital Hub, Inviting Fitness and Wellness Professionals to Collaborate
• Brilliant Minds to Gather in Fort Worth for National Mensa Event
• UK Financial Ltd Completes One Of The Most Extensive CoinMarketCap Supply Verification Packages For Maya Preferred PRA (MPRA)
• Data Tiles Strengthens U.S. Presence with Chief Revenue Officer John Goode

"Exora™ is not built on borrowed science," said Brian Pla, Founder & President at Exora™, "It is built from the ground up, through years of research, clinical insight, and a commitment to transparency. What we're introducing is not a trend, it's a long-term platform for the future of regenerative beauty. We are excited to announce that soon people will be able to enjoy our ExoCM formula at home as we are developing a transformational product for at-home use."

With a philosophy centered on integrity, performance, and scientific validation, Exora™ aims to set a new industry benchmark for how exosome-based technologies are developed, validated, and experienced across personal care.

For more information, visit www.exora.com or follow @exora.skinlabs (https://www.instagram.com/exora.skinlabs/) on Instagram.

For information on JuveXO, visit www.juvexo.com or follow @juvexo_official on Instagram.